A study of 2,600 patients in China found giving rectal indometacin before endoscopic retrograde cholangiopancreatography helped prevent pancreatitis. Dr. B. Joseph Elmunzer of the Medical University of South Carolina commented that the use of indometacin in average-risk cases has been controversial, but the study shows it is reasonable and evidence-based to give the treatment to all patients who have risk for post-ERCP pancreatitis.
The Internal Revenue Service has released guidance on reporting requirements for health care coverage under the Affordable Care Act. The proposal addresses information-reporting requirements for providers of minimum essential health coverage under Section 6055 and for employers subject to information-reporting requirements under Section 6056.
Licorice root could help gastritis and peppermint may reduce irritable bowel syndrome symptoms, but folk remedies touted for digestive ailments need to be approached with caution and skepticism, says dietitian Tamara Duker Freuman. Licorice probably will not help heal an ulcer and peppermint should not be taken by people who have trouble with heartburn, she says. Meanwhile, activated charcoal supplements reduce intestinal gas odor and aloe might help constipation short-term, but Freuman said all types of home remedies and natural products can have serious side effects and interactions.
Solution-driven psychotherapy was associated with reduced fatigue and better quality of life over the short term among patients in remission from inflammatory bowel disease, according to new research. Patients in the treatment and control groups all demonstrated less anxiety, but those getting psychotherapy reported greater reductions in depression at three months. The effect did not last to nine months.
High-risk patients given one dose of rectal indomethacin right after endoscopic retrograde cholangiopancreatography had a lower likelihood of developing pancreatitis, University of Michigan Medical Center researchers reported in the New England Journal of Medicine. They noted that it is not known whether NSAIDs are better than temporary pancreatic stents for post-ERCP pancreatitis.